Patents Represented by Attorney, Agent or Law Firm D. Phil
  • Patent number: 6830885
    Abstract: This invention relates to the screening of nucleic acids. More particularly, the present invention provides a dysfunctional viral genome capable of both expressing libraries of exogenous nucleic acids and selecting the sequences having a predefined characteristic or function within the cell, such as nucleic acids encoding signal peptides, secreted proteins, membrane bound proteins, proteases and drug-resistance proteins. The invention further provides a method and a kit for selecting nucleic acids having a desired feature, wherein production of a viral particle is dependent on insertion of an exogenous nucleic acid having the desired feature into a dysfunctional viral genome or into a viral genome exposed to a substance inhibiting viral packaging function(s).
    Type: Grant
    Filed: August 18, 2000
    Date of Patent: December 14, 2004
    Assignee: Phenogene Therapeutiques Inc.
    Inventors: Christian Lanctot, Pierre Moffat, Patrick Salois